Señales en vivo de 003520.KS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 02:30):

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products...

Stats
Volumen de hoy	91 672.00
Volumen promedio	359 495
Capitalización de mercado	388.65B
EPS	KRW0 ( 2024-02-05 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-07
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	-34.51
ATR14	KRW2.23 (0.10%)

Volumen Correlación

Largo: 0.03 (neutral)

Corto: 0.51 (weak)

Signal:(54.26) Neutral

Yungjin Pharm. Co., Ltd. Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yungjin Pharm. Co., Ltd. Correlación - Moneda/Commodity

0.52
( weak )

0.61
( weak )

-0.09
( neutral )

0.60
( weak )

-0.72
( moderate negative )

Yungjin Pharm. Co., Ltd. Finanzas

Annual	2023
Ingresos:	KRW234.90B
Beneficio Bruto:	KRW70.94B (30.20 %)
EPS:	KRW-21.19

FY	2023
Ingresos:	KRW234.90B
Beneficio Bruto:	KRW70.94B (30.20 %)
EPS:	KRW-21.19

FY	2022
Ingresos:	KRW218.38B
Beneficio Bruto:	KRW64.73B (29.64 %)
EPS:	KRW-120.08

FY	2021
Ingresos:	KRW196.07B
Beneficio Bruto:	KRW57.94B (29.55 %)
EPS:	KRW-63.33

Financial Reports:

No articles found.

Yungjin Pharm. Co., Ltd.

Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea. It provides cephalosporin antibiotic, antipsychotic, cardiovascular, and nutrition products. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. is a subsidiary of KT&G Corporation.

Actualizaciones en tiempo real para Yungjin Pharm. Co., Ltd. [003520.KS]

Upcoming Earnings Alert